Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment [0.03%]
与代谢功能障碍相关的脂肪肝疾病：一种具有异质性代谢危险因素、机制和共病需要整体治疗的状况
Christopher D Byrne,Angelo Armandi,Vanessa Pellegrinelli et al.
Christopher D Byrne et al.
Μetabolic dysfunction-associated steatotic liver disease (MASLD) comprises a heterogeneous condition in the presence of steatotic liver. There can be a hierarchy of metabolic risk factors contributing to the severity of metabolic dysfuncti...
Diane M Tshikudi,Charles N Bernstein,Suresh Mishra et al.
Diane M Tshikudi et al.
The incidence of inflammatory bowel disease (IBD) has risen in the past decades and has emerged as a global health issue. IBD is characterized by chronic inflammation of the gastrointestinal tract. There is compelling evidence for the role ...
Author Correction: Understanding the therapeutic toolkit for inflammatory bowel disease [0.03%]
作者更正：理解炎症性肠病的治疗工具包
Sophie Vieujean,Vipul Jairath,Laurent Peyrin-Biroulet et al.
Sophie Vieujean et al.
Published Erratum
Nature reviews. Gastroenterology & hepatology. 2025 Feb 10. DOI:10.1038/s41575-025-01047-x 2025
Ahsen Ustaoglu
Ahsen Ustaoglu
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed [0.03%]
开发新有效的HBV复制抑制剂以治疗慢性乙型肝炎刻不容缓
Timothy M Block,Ju-Tao Guo,Fabien Zoulim et al.
Timothy M Block et al.
Silvia Sookoian,Carlos J Pirola,Arun J Sanyal
Silvia Sookoian
Silvia Turroni
Silvia Turroni
Sophie Vieujean,Vipul Jairath,Laurent Peyrin-Biroulet et al.
Sophie Vieujean et al.
Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, is a group of chronic, immune-mediated disorders of the gastrointestinal tract that present substantial clinical challenges owing to their complex pathop...
Katrina Ray
Katrina Ray